Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
2.
PLoS Pathog ; 15(2): e1007567, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30789961

RESUMEN

Most studies of T lymphocytes focus on recognition of classical major histocompatibility complex (MHC) class I or II molecules presenting oligopeptides, yet there are numerous variations and exceptions of biological significance based on recognition of a wide variety of nonclassical MHC molecules. These include αß and γδ T cells that recognize different class Ib molecules (CD1, MR-1, HLA-E, G, F, et al.) that are nearly monomorphic within a given species. Collectively, these T cells can be considered "unconventional," in part because they recognize lipids, metabolites, and modified peptides. Unlike classical MHC-specific cells, unconventional T cells generally exhibit limited T-cell antigen receptor (TCR) repertoires and often produce innate immune cell-like rapid effector responses. Exploiting this system in new generation vaccines for human immunodeficiency virus (HIV), tuberculosis (TB), other infectious agents, and cancer was the focus of a recent workshop, "Immune Surveillance by Non-classical MHC Molecules: Improving Diversity for Antigens," sponsored by the National Institute of Allergy and Infectious Diseases. Here, we summarize salient points presented regarding the basic immunobiology of unconventional T cells, recent advances in methodologies to measure unconventional T-cell activity in diseases, and approaches to harness their considerable clinical potential.


Asunto(s)
Vigilancia Inmunológica/inmunología , Complejo Mayor de Histocompatibilidad/inmunología , Animales , Antígenos , Antígenos HLA , Antígenos de Histocompatibilidad Clase I/inmunología , Antígenos de Histocompatibilidad Clase II/inmunología , Humanos , Receptores de Antígenos de Linfocitos T , Receptores de Antígenos de Linfocitos T alfa-beta/inmunología , Linfocitos T/inmunología
3.
J Racial Ethn Health Disparities ; 10(4): 2039-2053, 2023 08.
Artículo en Inglés | MEDLINE | ID: mdl-36068482

RESUMEN

The heroin epidemic has existed for decades, but a sharp rise in opioid overdose deaths (OODs) jolted the nation in the mid-twenty-teens and continues as a major health crisis to this day. Although the new wave of OODs was initially approached as a rural problem impacting a White/Caucasian demographic, surveillance records suggest severe impacts on African Americans and urban-dwelling individuals, which have been largely underreported. The focus of this report is on specific trends in OOD rates in Black and White residents in states with a significant Black urban population and declared as hotspots for OOD: (Maryland (MD), Illinois (IL), Michigan (MI), and Pennsylvania (PA)), and Washington District of Columbia (DC). We compare OODs by type of opioid, across ethnicities, across city/rural demographics, and to homicide rates using 2013-2020 data acquired from official Chief Medical Examiners' or Departments of Health (DOH) reports. With 2013 or 2014 as baseline, the OOD rate in major cities (Baltimore, Chicago, Detroit, Philadelphia) were elevated two-fold over all other regions of their respective state. In DC, Wards 7 and 8 OODs were consistently greater than other jurisdictions, until 2020 when the rate of change of OODs increased for the entire city. Ethnicity-wise, Black OOD rates exceeded White rates by four- to six-fold, with fentanyl and heroin having a disproportionate impact on Black opioid deaths. This disparity was aggravated by its intersection with the COVID-19 pandemic in 2020. African Americans and America's urban dwellers are vulnerable populations in need of social and political resources to address the ongoing opioid epidemic in under-resourced communities.


Asunto(s)
Negro o Afroamericano , Disparidades en Atención de Salud , Sobredosis de Opiáceos , Epidemia de Opioides , Determinantes Sociales de la Salud , Población Urbana , Adolescente , Humanos , Analgésicos Opioides/efectos adversos , Negro o Afroamericano/estadística & datos numéricos , COVID-19/epidemiología , COVID-19/etnología , Heroína/envenenamiento , Epidemia de Opioides/estadística & datos numéricos , Epidemia de Opioides/tendencias , Pandemias , Philadelphia/epidemiología , Estados Unidos/epidemiología , Población Urbana/estadística & datos numéricos , Blanco/estadística & datos numéricos , Sobredosis de Opiáceos/epidemiología , Sobredosis de Opiáceos/etnología , Sobredosis de Opiáceos/mortalidad , Determinantes Sociales de la Salud/etnología , Determinantes Sociales de la Salud/estadística & datos numéricos , Determinantes Sociales de la Salud/tendencias , Disparidades en Atención de Salud/etnología , Disparidades en Atención de Salud/estadística & datos numéricos , Disparidades en Atención de Salud/tendencias , Disparidades en el Estado de Salud
4.
J Biomed Inform ; 44(1): 75-9, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20123131

RESUMEN

The Cell Ontology (CL) aims for the representation of in vivo and in vitro cell types from all of biology. The CL is a candidate reference ontology of the OBO Foundry and requires extensive revision to bring it up to current standards for biomedical ontologies, both in its structure and its coverage of various subfields of biology. We have now addressed the specific content of one area of the CL, the section of the ontology dealing with hematopoietic cells. This section has been extensively revised to improve its content and eliminate multiple inheritance in the asserted hierarchy, and the groundwork has been laid for structuring the hematopoietic cell type terms as cross-products incorporating logical definitions built from relationships to external ontologies, such as the Protein Ontology and the Gene Ontology. The methods and improvements to the CL in this area represent a paradigm for improvement of the entire ontology over time.


Asunto(s)
Células Sanguíneas/citología , Hematopoyesis , Informática Médica , Vocabulario Controlado , Animales , Humanos
5.
Radiat Res ; 164(1): 100-9, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15966769

RESUMEN

Current events throughout the world underscore the growing threat of different forms of terrorism, including radiological or nuclear attack. Pharmaceutical products and other approaches are needed to protect the civilian population from radiation and to treat those with radiation-induced injuries. In the event of an attack, radiation exposures will be heterogeneous in terms of both dose and quality, depending on the type of device used and each victim's location relative to the radiation source. Therefore, methods are needed to protect against and treat a wide range of early and slowly developing radiation-induced injuries. Equally important is the development of rapid and accurate biodosimetry methods for estimating radiation doses to individuals and guiding clinical treatment decisions. Acute effects of high-dose radiation include hematopoietic cell loss, immune suppression, mucosal damage (gastrointestinal and oral), and potential injury to other sites such as the lung, kidney and central nervous system (CNS). Long-term effects, as a result of both high- and low-dose radiation, include dysfunction or fibrosis in a wide range of organs and tissues and cancer. The availability of appropriate types of animal models, as well as adequate numbers of animals, is likely to be a major bottleneck in the development of new or improved radioprotectors, mitigators and therapeutic agents to prevent or treat radiation injuries and of biodosimetry methods to measure radiation doses to individuals.


Asunto(s)
Modelos Animales de Enfermedad , Diseño de Fármacos , Traumatismos por Radiación/tratamiento farmacológico , Traumatismos por Radiación/prevención & control , Protección Radiológica/métodos , Protectores contra Radiación/uso terapéutico , Proyectos de Investigación , Animales , Humanos
6.
Int Immunopharmacol ; 3(3): 403-15, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12639818

RESUMEN

Gallium arsenide (GaAs) is utilized in industries for its semiconductor and optical properties. Chemical exposure of animals systemically suppresses several immune functions. The ability of splenic B cells to activate antigen-specific helper CD4(+) T cell hybridomas was assessed, and various aspects of antigen-presenting cell function were examined. GaAs-exposed murine B cells were impaired in processing intact soluble protein antigens, and the defect was antigen dependent. In contrast, B cells after exposure competently presented peptides to the T cells, which do not require processing. Cell surface expression of major histocompatibility complex (MHC) class II molecules and several costimulatory molecules on splenic B cells, which are critical for helper T cell activation, was not affected by chemical exposure. GaAs exposure also did not influence the stability of MHC class II heterodimers, suggesting that the defect may precede peptide exchange. GaAs-exposed B cells contained a normal level of aspartyl cathepsin activity; however, proteolytic activities of thiol cathepsins B and L were approximately half the control levels. Furthermore, two cleavage fragments of invariant chain, a molecular chaperone of MHC class II molecules, were increased in GaAs-exposed B cells, indicative of defective degradation. Thus, diminished thiol proteolytic activity in B cells may be responsible for their impaired antigen processing and invariant chain degradation, which may contribute to systemic immunosuppression caused by GaAs exposure.


Asunto(s)
Células Presentadoras de Antígenos/efectos de los fármacos , Linfocitos B/efectos de los fármacos , Galio/toxicidad , Inmunidad Celular/efectos de los fármacos , Bazo/citología , Animales , Anticuerpos Monoclonales/farmacología , Presentación de Antígeno/efectos de los fármacos , Células Presentadoras de Antígenos/inmunología , Antígenos/inmunología , Arsenicales , Linfocitos B/inmunología , Western Blotting , Catepsinas/biosíntesis , Catepsinas/metabolismo , Línea Celular , Electroforesis en Gel de Poliacrilamida , Endopeptidasas/metabolismo , Técnica del Anticuerpo Fluorescente , Regulación de la Expresión Génica/efectos de los fármacos , Genes MHC Clase II/genética , Ratones , Bazo/efectos de los fármacos , Bazo/inmunología
7.
J Immunol ; 170(2): 905-12, 2003 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-12517956

RESUMEN

The Ag-specific B cell receptor (BCR) expressed by B lymphocytes has two distinct functions upon interaction with cognate Ag: signal transduction (generation of intracellular second messenger molecules) and Ag internalization for subsequent processing and presentation. While it is known that plasma membrane domains, termed lipid rafts, are involved in BCR-mediated signal transduction, the precise role of plasma membrane lipid rafts in BCR-mediated Ag internalization and intracellular trafficking is presently unclear. Using a highly characterized model system, it was determined that while plasma membrane lipid rafts can be internalized by B lymphocytes, lipid rafts do not represent a major pathway for the rapid and efficient internalization of cell surface Ag-BCR complexes. Moreover, internalized plasma membrane lipid rafts are delivered to intracellular compartments distinct from those to which the bulk of internalized Ag-BCR complexes are delivered. These results demonstrate that B lymphocytes, like other cell types, possess at least two distinct endocytic pathways (i.e., clathrin-coated pits and plasma membrane lipid rafts) that deliver internalized ligands to distinct intracellular compartments. Furthermore, Ag-BCR complexes differentially access these two distinct internalization pathways.


Asunto(s)
Antígenos/metabolismo , Endocitosis/inmunología , Líquido Intracelular/inmunología , Líquido Intracelular/metabolismo , Microdominios de Membrana/fisiología , Receptores de Antígenos de Linfocitos B/fisiología , Animales , Linfocitos B/inmunología , Linfocitos B/metabolismo , Toxina del Cólera/inmunología , Toxina del Cólera/metabolismo , Peroxidasa de Rábano Silvestre/metabolismo , Humanos , Cinética , Sustancias Macromoleculares , Ratones , Transporte de Proteínas/inmunología , Transfección , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA